The Canadian COVID‑19 Funded Research Database

Back to main page

Displaying 291 through 300 of 442 results (Download Results)

Show results per page

Evaluation of Archway: A Guided Program for First-Year Student Success and Mental Health and Wellbeing

Kwan, Matthew | McMaster University | Operating Grant | $156,000

CIHR Ontario 2020

Immune response after COVID‑19 vaccination during maintenance therapy in immune-mediated inflammatory diseases: an observational cohort study (IMPACT)

Chandran, Vinod | University Health Network | Operating Grant | $499,800

CIHR Ontario 2021

Long-term protective immunity against SARS-CoV-2 virus in COVID‑19 patients

Nazy, Ishac | McMaster University | Operating Grant | $350,000

CIHR Ontario 2020

Post-Acute Complications of COVID-19: An International Cohort Study (PACS) Note that in a previous iteration, this proposal was titled PACMAN as indicated in some of the Letters of Support

Leong, Darryl | McMaster University | Operating Grant | $495,684

CIHR Ontario 2021

COVID-19 Variant Supplement – Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

Langlois, Marc-Andre | University of Ottawa | Operating Grant | $50,000

CIHR Ontario 2021

Autoimmunity as a novel mechanism in post-COVID syndrome

Baker, Andrew J | St. Michael's Hospital | Operating Grant | $269,500

CIHR Ontario 2021

COVID-19 Variant Supplement – Neutralizing Antibodies as SARS-CoV-2 Therapeutics

Rini, James M | University of Toronto | Operating Grant | $50,000

CIHR Ontario 2021

Evaluating the impact of COVID‑19 pandemic on primary care using real world data: focus mental health

Tu, Karen | North York General Hospital | Operating Grant | $200,000

CIHR Ontario 2020

Adapting a holistic program to support the mental health and wellness of front line workers providing care to homeless and street communities

Gifford, Wendy A | University of Ottawa | Operating Grant | $197,250

CIHR Ontario 2020

COVID-19 Variant Supplement – Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.

Kozak, Robert A | University of Toronto | Operating Grant | $44,460

CIHR Ontario 2021

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback